Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. GDNF-Enhanced Axonal Regeneration and Myelination Following Spinal Cord Injury is Mediated by Primary Effects on Neurons

GDNF-Enhanced Axonal Regeneration and Myelination Following Spinal Cord Injury is Mediated by Primary Effects on Neurons

Glia, 2009 · DOI: 10.1002/glia.20840 · Published: August 15, 2009

Spinal Cord InjuryRegenerative MedicineNeurology

Simple Explanation

This research investigates how GDNF, a growth factor, affects nerve regeneration and myelin formation after spinal cord injury (SCI). The study focuses on whether GDNF directly impacts neurons or indirectly affects Schwann cells (SCs), which are crucial for nerve repair. The findings indicate that GDNF has a direct positive effect on neurons, enhancing their growth and regeneration. GDNF also influences SCs by increasing the production of a specific adhesion molecule, NCAM, which aids in nerve-SC interaction. Overall, the study suggests that GDNF primarily acts on neurons to promote nerve regeneration and myelin formation after SCI, with a secondary influence on SC function. This combined effect makes GDNF a promising therapeutic agent for spinal cord repair.

Study Duration
2, 4, and 6 weeks
Participants
Adult female SD rats (180–200 grams, Harlan), embryonic (E) day 15 SD rats, neonatal (postnatal day 1) rats
Evidence Level
Not specified

Key Findings

  • 1
    GDNF enhances both the number and caliber of regenerated axons in vivo and increases neurite outgrowth of dorsal root ganglion neurons (DRGN) in vitro, suggesting that GDNF has a direct effect on neurons.
  • 2
    GDNF treatment had no effect on the proliferation of isolated SCs but enhanced the proliferation of SCs already in contact with axons.
  • 3
    GDNF increased the expression of the 140 kDa neural cell adhesion molecule (NCAM) in isolated SCs

Research Summary

This study investigates the effects of GDNF on axonal regeneration and myelination following SCI, focusing on whether GDNF acts directly on neurons or indirectly through SCs. The results indicate that GDNF has a primary, direct effect on neurons, promoting axonal regeneration and increasing axon caliber. GDNF also enhances SC myelination and increases NCAM expression in SCs. The study concludes that GDNF-enhanced axonal regeneration and myelination are primarily mediated by its direct effect on neurons, suggesting that combining GDNF administration with SC transplantation could be an effective strategy for spinal cord repair.

Practical Implications

Therapeutic Potential

GDNF, in conjunction with SC transplantation, could be an effective therapeutic strategy for promoting axonal regeneration and myelin formation after spinal cord injury.

Drug Development

The study highlights GDNF as a potential drug target for SCI, emphasizing its direct influence on neurons and its secondary effects on SCs.

Cellular Mechanisms

Understanding the mechanisms by which GDNF enhances axonal regeneration and myelination can help develop targeted therapies for nerve repair.

Study Limitations

  • 1
    The precise mechanisms by which GDNF increases the diameter of regenerated axons remain unclear.
  • 2
    The study did not differentiate between increased axon caliber due to caliber increase of existing regenerated axons or the recruitment of additional large caliber axons.
  • 3
    Whether proliferation of SCs was a result of direct contact with axons or indirectly through factors released from axons remains to be investigated.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury